Extracorporeal Shock Wave Therapy for Chronic Painful Heel Syndrome: A Prospective, Double Blind, Randomized Trial Assessing the Efficacy of a New Electromagnetic Shock Wave Device

Gollwitzer, Hans; Diehl, Paula; Korff, A. von; Rahlfs, Volker W.; Gerdesmeyer, Ludger

doi:10.1053/j.jfas.2007.05.011

Cited by 96 publications

(56 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2). Two studies reported on absolute reductions in VAS scores for heel pain [7,9]. There was no significant heterogeneity between these two trials (df = 1; I 2 = 0; Q = 0.00; p = 0.69).…”

Section: Resultsmentioning

confidence: 99%

“…5). Two studies contributed to the analysis of success rate of heel pain improvement while doing daily activities [6,7]. There was no significant heterogeneity between these two trials (df = 1; I 2 = 0; Q = 0.19; p = 0.66).…”

Section: Resultsmentioning

confidence: 99%

“…6). Two studies contributed to the analysis of the success rate of heel pain improvement after application of a pressure meter [6,7].…”

Section: Resultsmentioning

confidence: 99%

“…7). Three studies contributed to the assessment [6][7][8]. As the data were not continuous, it was deemed more appropriate to discuss the results of the trials individually.…”

Section: Placebo 23mentioning

confidence: 99%

See 3 more Smart Citations

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

106

View full text Add to dashboard Cite

Background Plantar fasciitis is the most common cause of heel pain. It may remain symptomatic despite conservative treatment with orthoses and analgesia. There is conflicting evidence concerning the role of extracorporeal shock wave therapy (ESWT) in the management of this condition. Questions/purposes We investigated whether there was a significant difference in the change of (1) VAS scores and (2) Roles and Maudsley scores from baseline when treated with ESWT and placebo. Specifically we compared overall improvement from baseline composite VAS, reduction in overall VAS pain, success rate of improving overall VAS pain by 60%, success rate of improving VAS pain by 60% when taking first steps, doing daily activities, and during application of a pain pressure meter.Methods MEDLINE, Embase, and CINAHL databases were searched from January 1980 to January 2013 and a double extraction technique was used to obtain relevant studies. Studies had to be prospective randomized controlled trials on adults and must not have used local anesthesia as part of their treatment protocol. Studies must have specifically recruited patients who continued to be symptomatic despite a minimum of 3 months of conservative treatments. All papers were assessed regarding their methodologic quality and a meta-analysis performed. Seven prospective randomized controlled trials were included in this study. There were 369 patients included in the placebo group and 294 in the ESWT group. Results After ESWT, patients had better composite VAS scores (random effects model, standardized mean difference [SMD] = 0.38; 95% CI, 0.05, 0.72; z = 2.27). They also had a greater reduction in their absolute VAS scores compared with placebo (random effects model, SMD = 0.60; 95% CI, 0.34, 0.85; z = 4.64). Greater success of improving heel pain by 60% was observed after ESWT when taking first steps (random effects model, risk ratio [RR] = 1.30; 95% CI, 1.04, 1.62; z = 2.29) and during daily activities (random effects model, RR = 1.44; 95% CI, 1.13, 1.84; z = 2.96). Subjective measurement of pain using a pressure meter similarly favored ESWT (random effects model, RR = 1.37, 95% CI, 1.06, 1.78; z = 2.41). There was a significant difference in the change to

show abstract

“…2). Two studies reported on absolute reductions in VAS scores for heel pain [7,9]. There was no significant heterogeneity between these two trials (df = 1; I 2 = 0; Q = 0.00; p = 0.69).…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…6). Two studies contributed to the analysis of the success rate of heel pain improvement after application of a pressure meter [6,7].…”

Section: Resultsmentioning

confidence: 99%

“…7). Three studies contributed to the assessment [6][7][8]. As the data were not continuous, it was deemed more appropriate to discuss the results of the trials individually.…”

Section: Placebo 23mentioning

confidence: 99%

See 2 more Smart Citations

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

106

View full text Add to dashboard Cite

show abstract

“…4 Although the effect of ESWT remains controversial, reliable evidence supports the use of this approach for treating chronic plantar fasciitis . 5,6 However, adverse effects such as pain during treatment, soft tissue damage (bleeding, hematoma, paresthesia), nausea, the need for peripheral nerve block and costs should be considered when proposing this procedure 7 .…”

Section: Introductionmentioning

confidence: 99%

A randomized control study to assess the efficacy of platelet rich plasma and local corticosteroid injection in treatment of chronic plantar fasciitis

2020

IJOS

View full text Add to dashboard Cite

Plantar Fasciitis

Fullem

Saxena²

2012

International Advances in Foot and Ankle Surgery

View full text Add to dashboard Cite

Extracorporeal Shock Wave Therapy for Chronic Painful Heel Syndrome: A Prospective, Double Blind, Randomized Trial Assessing the Efficacy of a New Electromagnetic Shock Wave Device

Cited by 96 publications

References 34 publications

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

A randomized control study to assess the efficacy of platelet rich plasma and local corticosteroid injection in treatment of chronic plantar fasciitis

Plantar Fasciitis

Contact Info

Product

Resources

About